See also this year's filing and all EDGAR filings for this company.
PDF Report 0001729427_2024_CNS_Pharmaceuticals_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001729427, CNS Pharmaceuticals Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 1,591,170 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 4,933 |
| 3 | remainder_Assets | 104,750 |
| 4 | LiabilitiesCurrent | 6,132,968 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 4,769,502 |
| 9 | ResearchAndDevelopmentExpense | 14,095,606 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 13,882 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 1,700,853 |
| 1 | Liabilities | 6,132,968 |
| 2 | Expenses | 18,865,108 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | -4,432,115 |
| 5 | NetIncome | -18,851,226 |
| 6 | ComprehensiveNetIncome | -18,851,226 |
| 7 | BaseVar | 13,356,406 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -7.28 |
| 9 | EconomicCapitalRatio | 0.0203 |
Edgar->Model Mapping
Feature Distribution
